+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurological Care and the COVID-19 Pandemic

  • Book

  • August 2021
  • Elsevier Health Science
  • ID: 5275411
Offering a comprehensive review of the neuropathology of SARS-CoV-2,�Neurological Care and the COVID-19 Pandemic�provides up-to-date coverage of the wide array of the pathogen's neurological symptoms and complications. Drs.�Ahmad Riad Ramadan and�Gamaledin�Osman�discuss�the neuropathology of SARS-CoV-2, its neurological manifestations,�and the impact the pandemic has had on the care of patients with pre-existing neurological conditions. The authors also offer an overview of emerging treatments and vaccines, as well as ways healthcare systems have reorganized in order to respond to the pandemic.
  • Offers�a thorough discussion of the impact the virus has had on the care of patients with neurological ailments, accompanied by recommendations on how to care for these patients.�

  • Covers the impact of COVID-19 on patients with�cerebrovascular diseases, seizures, demyelinating diseases, neuromuscular disorders, movement disorders, headache disorders, cognitive disorders, and neuro-oncological disorders.�

  • Includes a detailed case study of how one healthcare system hit hard by COVID-19 successfully transformed itself to respond to the challenges imposed by the pandemic.�

  • Consolidates today's available information on this timely topic into a single, convenient resource.�

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Fears and hopes
2. Neuropathogenesis of SARS-CoV-2 infection
3. Neurological presentations of COVID-19
4. COVID-19 and cerebrovascular diseases
5. COVID-19 and seizures
6. COVID-19 and autoimmune demyelinating diseases
7. COVID-19 and neuromuscular disorders
8. Pediatric neurology and the COVID-19 pandemic
9. Neuro-oncologic care during the COVID-19 pandemic
10. COVID-19 infection: Impaired olfaction, movement disorders, encephalopathy, and neuropsychiatric manifestations
11. COVID-19 and headache disorders
12. Treatment approach, pharmacological agents and vaccines
13. Response of healthcare systems to the pandemic
Appendix: Medications

Authors

Ahmad Riad Ramadan Neurologist, Stroke and Neurocritical Care, Henry Ford Neuroscience Institute, Henry Ford Hospital, Detroit, Michigan. Ahmad Riad Ramadan is a vascular neurologist and neurointensivist at the Henry Ford Neuroscience Institute, Henry Ford Hospital, Detroit, MI, USA. He also is the program director for the Neurocritical Care Fellowship and chairs the Scientific Advisory Board of the Department of Neurology. Gamaleldin Osman Epilepsy fellow at Mayo Clinic Hospital and Assistant Professor at Mayo School of Medicine, Rochester, MN, United States. Gamaleldin Osman is at the Mayo Clinic Comprehensive Epilepsy Center, Neurology Department, in Rochester, Minnesota.